Casas M, Dickson E
Contact (Thousand Oaks). 2025; 7:25152564241305593.
PMID: 39742107
PMC: 11686659.
DOI: 10.1177/25152564241305593.
Maghsoudi S, Shuaib R, Van Bastelaere B, Dakshinamurti S
Front Pharmacol. 2024; 15:1370506.
PMID: 38633617
PMC: 11021717.
DOI: 10.3389/fphar.2024.1370506.
Hou W, Yin S, Li P, Zhang L, Chen T, Qin D
Cell Mol Life Sci. 2024; 81(1):164.
PMID: 38575795
PMC: 10995029.
DOI: 10.1007/s00018-024-05198-z.
Fu Q, Wang Y, Yan C, Xiang Y
Physiol Rev. 2023; 104(2):765-834.
PMID: 37971403
PMC: 11281825.
DOI: 10.1152/physrev.00015.2023.
Klaver D, Thurnher M
Purinergic Signal. 2023; 19(3):501-511.
PMID: 37016172
PMC: 10073626.
DOI: 10.1007/s11302-023-09932-3.
Diversity of cells and signals in the cardiovascular system.
Grandi E, Navedo M, Saucerman J, Bers D, Chiamvimonvat N, Dixon R
J Physiol. 2023; 601(13):2547-2592.
PMID: 36744541
PMC: 10313794.
DOI: 10.1113/JP284011.
Oxidative Regulation of Vascular Ca1.2 Channels Triggers Vascular Dysfunction in Hypertension-Related Disorders.
Hu X, Zhang L
Antioxidants (Basel). 2022; 11(12).
PMID: 36552639
PMC: 9774363.
DOI: 10.3390/antiox11122432.
Functional tuning of Vascular L-type Ca channels.
Mironova G, Haghbin N, Welsh D
Front Physiol. 2022; 13:1058744.
PMID: 36457306
PMC: 9705771.
DOI: 10.3389/fphys.2022.1058744.
Spatiotemporal Control of Vascular Ca1.2 by α1 S1928 Phosphorylation.
Martin-Aragon Baudel M, Flores-Tamez V, Hong J, Reddy G, Maillard P, Burns A
Circ Res. 2022; 131(12):1018-1033.
PMID: 36345826
PMC: 9722584.
DOI: 10.1161/CIRCRESAHA.122.321479.
Ion channel molecular complexes in vascular smooth muscle.
Pereira da Silva E, Martin-Aragon Baudel M, Navedo M, Nieves-Cintron M
Front Physiol. 2022; 13:999369.
PMID: 36091375
PMC: 9459047.
DOI: 10.3389/fphys.2022.999369.
Mechanisms and physiological implications of cooperative gating of clustered ion channels.
Dixon R, Navedo M, Binder M, Santana L
Physiol Rev. 2021; 102(3):1159-1210.
PMID: 34927454
PMC: 8934683.
DOI: 10.1152/physrev.00022.2021.
Adrenergic Regulation of Calcium Channels in the Heart.
Papa A, Kushner J, Marx S
Annu Rev Physiol. 2021; 84:285-306.
PMID: 34752709
PMC: 9573788.
DOI: 10.1146/annurev-physiol-060121-041653.
Genetically engineered mice for combinatorial cardiovascular optobiology.
Lee F, Lee J, Shui B, Reining S, Jibilian M, Small D
Elife. 2021; 10.
PMID: 34711305
PMC: 8555989.
DOI: 10.7554/eLife.67858.
Purinergic Regulation of Endothelial Barrier Function.
Aslam M, Gunduz D, Troidl C, Heger J, Hamm C, Schulz R
Int J Mol Sci. 2021; 22(3).
PMID: 33530557
PMC: 7865261.
DOI: 10.3390/ijms22031207.
Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert K, Castro M, Assmann C, Bottari N, Miron V, Cardoso A
Biomed Pharmacother. 2021; 137:111273.
PMID: 33524787
PMC: 7846467.
DOI: 10.1016/j.biopha.2021.111273.
P2Y11 Agonism Prevents Hypoxia/Reoxygenation- and Angiotensin II-Induced Vascular Dysfunction and Intimal Hyperplasia Development.
Piollet M, Sturza A, Chadet S, Gabillard-Lefort C, Benoist L, Muntean D
Int J Mol Sci. 2021; 22(2).
PMID: 33467058
PMC: 7829863.
DOI: 10.3390/ijms22020855.
TMEM16A channel upregulation in arterial smooth muscle cells produces vasoconstriction during diabetes.
Leo M, Peixoto-Nieves D, Yin W, Raghavan S, Muralidharan P, Mata-Daboin A
Am J Physiol Heart Circ Physiol. 2021; 320(3):H1089-H1101.
PMID: 33449847
PMC: 7988758.
DOI: 10.1152/ajpheart.00690.2020.
Tissue-specific adrenergic regulation of the L-type Ca channel Ca1.2.
Man K, Bartels P, Horne M, Hell J
Sci Signal. 2021; 13(663).
PMID: 33443233
PMC: 7909005.
DOI: 10.1126/scisignal.abc6438.
AKAP5 complex facilitates purinergic modulation of vascular L-type Ca channel Ca1.2.
Prada M, Syed A, Reddy G, Martin-Aragon Baudel M, Flores-Tamez V, Sasse K
Nat Commun. 2020; 11(1):5303.
PMID: 33082339
PMC: 7575592.
DOI: 10.1038/s41467-020-18947-y.
Purinergic System Signaling in Metainflammation-Associated Osteoarthritis.
Gratal P, Lamuedra A, Medina J, Bermejo-Alvarez I, Largo R, Herrero-Beaumont G
Front Med (Lausanne). 2020; 7:506.
PMID: 32984382
PMC: 7485330.
DOI: 10.3389/fmed.2020.00506.